FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: December 31, 2014 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person * JORDAN CLARK LINDBERG (Last) (First) (Middle) 200 S. WILCOX DRIVE (Street) KINGSPORT TN 37660 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/01/2019	3. Issuer Name and Ticker or Trading Symbol EASTMAN CHEMICAL CO [ EMN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP, CLO and Corp. Sec'y	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,491	D
Common Stock	1,025	I	By ESOP

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/28/2020 (1)	02/27/2029	Common Stock	5,166	82.69	D
Employee Stock Option (right to buy)	02/26/2019 (2)	02/25/2028	Common Stock	5,127	104.21	D
Employee Stock Option (right to buy)	02/28/2018 (3)	02/27/2027	Common Stock	16,225	80.25	D
Employee Stock Option (right to buy)	02/26/2019	02/25/2026	Common Stock	4,843	65.16	D
Employee Stock Option (right to buy)	02/27/2018	02/26/2025	Common Stock	3,463	74.46	D
Employee Stock Option (right to buy)	02/28/2017	02/27/2024	Common Stock	1,797	87.43	D
Employee Stock Option (right to buy)	02/28/2016	02/27/2023	Common Stock	1,682	69.73	D
Restricted Stock Units	02/28/2020 (4)	02/28/2020 (4)	Common Stock	1,750	(4)	D

Explanation of Responses:

1. One-third of option becomes excercisable on each of February 28, 2020, February 28, 2021, and February 28, 2022.

2. One-third of option became excercisable on February 26, 2019 and one-third of option becomes excercisable on each of February 26, 2020 and February 26, 2021.

3. One-third of option became excercisable on each of February 28, 2018 and February 28, 2019 and one-third of option becomes execercisable on February 28, 2020.

4. Each Restricted Stock Unit represents a contingent right to receive one share of issuer common stock subject to continued employment.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian L. Henry, by Power of Attorney	08/08/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

                               POWER OF ATTORNEY

     Know all by these presents that the undersigned hereby constitutes and
appoints each of David A. Golden and Brian L. Henry, signing singly, the
undersigned's true and lawful attorney-in-fact to:

     (1)  execute for and on behalf of the undersigned, in the undersigned's
capacity as a director of Eastman Chemical Company (the "Company"), Forms 3, 4,
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder;

     (2)  do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4,
or 5 and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and

     (3)  take any other action of any type whatsoever in connection with
preparation and filing of disclosure and reports related to ownership and
acquisitions or dispositions of Company securities, including Forms 144
reporting planned sales of Company securities, which, in the opinion of such
attorney-in-fact, may be of benefit to, and in the best interest of, or legally
required by, the undersigned.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the
Securities Act of 1933.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 2nd day of August 2019.



                                          /s/ Clark L. Jordan
                                    -----------------------------------
                                             Clark L. Jordan

SEC Filings